Home | Sitemap | Search | ContactA- A A+
   
 
    Public Member Support us  
 

IBCSG 27-02 / BIG 1-02 (CALOR) 

A randomized clinical trial of adjuvant chemotherapy for radically resected loco-regional relapse of breast cancer

Chemotherapy as Adjuvant for LOcally Recurrent (CALOR)

Chemotherapy vs. observation

DESIGN

Design 27-02

Results & Publications


Publications

Study Chairs
Prof. Stefan Aebi - Bern, Switzerland
Dr. Irene Wapnir - Stanford, USA

Statistician
Dr. Meredith Regan

Lead Trial Coordinator
Holly Shaw

Data Managers
Karolyn Scott

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 833 3990
Email: ibcsg27@fstrf.org

Date of Activation
July 31, 2002

Targeted Accrual
977 patients


Results Publications Results & Publications
Other Pathology


News

23.03.2018:
The next IBCSG Annual Meeting will take place in Barcelona, Spain on March 23 and 24, 2018

03.09.2017:
RACE FOR LIFE - mit Power gegen Krebs am 3. September 2017 in Bern  

15.06.2017:
PINK GOLF TOUR 2017 für die Brustkrebs-Prävention  

All News

 
  Print